Drug & supplement interaction

N,n-dmpea + Inotuzumab Ozogamicin

Inotuzumab Ozogamicin brand name: Besponsa.

No Known Interaction
Medically reviewed by · Updated June 2026 · Pair last verified Sep 13, 2026
The bottom line No known interaction

We found no known interaction between N,n-dmpea and Inotuzumab Ozogamicin in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Facebook Post Reddit Email
On this page
Interaction report

N,n-dmpea and Inotuzumab Ozogamicin

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Inotuzumab Ozogamicin and N,n-dmpea in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

N,n-dmpea safety at a glance

N,n-dmpea overall Use caution Human safety data are very limited, and stimulant-like effects are possible.
Pregnancy Avoid No safety data exist, so it should be avoided during pregnancy.
Breastfeeding Avoid No safety data exist, so it should be avoided while breastfeeding.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Inotuzumab Ozogamicin and N,n-dmpea? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Inotuzumab Ozogamicin

Interactions in our licensed database are recorded against drug classes, not just single drug names. Inotuzumab Ozogamicin is filed under a single classification — qt interval-prolonging drugs. N,n-dmpea has documented interactions with 1 drug class — the most serious being cytochrome p450 2d6 (cyp2d6) substrates (moderate) — and none of Inotuzumab Ozogamicin’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

N,n-dmpea Does Interact With Other Medications

N,n-dmpea has 193 moderate known drug interactions in our database — Inotuzumab Ozogamicin isn’t one of them. If you take anything else, check it against the full list below.

Moderate 193 No known interaction 2,637 (incl. Inotuzumab Ozogamicin)
Taking anything else?

Check Another of Your Medications Against N,n-dmpea

Covers the 2,830 medications we’ve checked against N,n-dmpea. Pick one to open its full report.

What to actually watch for

What Inotuzumab Ozogamicin’s Own FDA Label Lists

This is not an interaction — none of it involves N,n-dmpea. These are the most notable effects listed in the ADVERSE REACTIONS section of Inotuzumab Ozogamicin’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 10 of them are worth acting on rather than waiting out — marked below.

  • Muscle weakness Worth acting on
  • Yellowing of the skin or eyes Worth acting on
  • An irregular heartbeat Worth acting on
  • A low platelet count Worth acting on
  • Anemia Worth acting on
  • Shortness of breath Worth acting on
  • A low white blood cell count Worth acting on
  • Liver problems Worth acting on
  • Bleeding or bruising Worth acting on
  • A higher chance of infection Worth acting on

Showing the 10 most notable of 38 label-listed effects — ranked by how unusual each one is across medicines generally, with serious effects weighted up.

From the ADVERSE REACTIONS section of the FDA label for Inotuzumab Ozogamicin. Read the label on DailyMed › N,n-dmpea’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no N,n-dmpea side to compare — that is a limit of the record, not a statement that N,n-dmpea has no side effects.

Everything else you take

See Every Supplement That Interacts With Inotuzumab Ozogamicin

This page covers N,n-dmpea only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Inotuzumab Ozogamicin page lists 13 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: American Hellebore (major), Arsenic (major), Cesium (major), Ephedra (major) and Grapefruit (major).

By severity: 6 major · 7 moderate.

From our pharmacist’s overview on the Inotuzumab Ozogamicin page

“Every supplement on this page interacts with inotuzumab ozogamicin (Besponsa) in the same way, by adding to the drug's own known tendency to prolong the QT interval, the heart's electrical reset time, which raises the risk of dangerous rhythm problems. Besponsa is chemotherapy for a form of acute leukemia, so my advice is to clear any…”

Reviewed by 2 · Jul 18, 2026

Open the Inotuzumab Ozogamicin interaction page

How much people look this up

Where N,n-dmpea and Inotuzumab Ozogamicin Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement N,n-dmpea
Steady interest

#1,340 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Inotuzumab Ozogamicin
Top 25%

#678 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every N,n-dmpea reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The N,n-dmpea and Inotuzumab Ozogamicin records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About N,n-dmpea

What is N,n-dmpea?

  • Mood or energy support
  • Pre-workout or stimulant effect
  • Cognitive or focus support

N,N-DMPEA (N,N-dimethylphenethylamine) is a synthetic relative of phenethylamine sometimes marketed in stimulant or pre-workout supplements. There is very little reliable human research on its effects or safety, and it is not a well-established dietary ingredient, so it should be approached with real caution.

Powder, capsules, research chemical

An interaction check asks whether these two react with each other — it does not ask whether N,n-dmpea is a good idea for someone in your situation. Here is what our N,n-dmpea record says about it on its own.

N,n-dmpea: dosing

There is no established or standardized safe dose of N,N-DMPEA. Because it has not been properly studied in humans, no reliable dosing guidance exists.If a product contains it, follow the product label, but understand that label amounts may not be accurate or safe.

From our N,n-dmpea monograph — the full record covers uses, side effects and every documented interaction.

Read the full N,n-dmpea monograph & all interactions
Medication

About Inotuzumab Ozogamicin Injection

What Is Inotuzumab Ozogamicin Injection Used For?

Brand name: Besponsa

Besponsa is approved to treat relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia (ALL) — a type of blood cancer that has come back or has not responded to previous treatment. It is approved for both adult and pediatric patients 1 year of age and older.

ALL is a fast-moving cancer of the blood and bone marrow. Besponsa specifically targets leukemia cells that carry a protein called CD22 on their surface, making it a targeted therapy rather than a general chemotherapy.

See full Inotuzumab Ozogamicin Injection drug information
Keep checking

Other Drugs & N,n-dmpea

Browse every other medication we’ve checked against N,n-dmpea — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
193Moderate
0Minor
2,636No known interaction
193 Moderate 2,636 No interaction
Moderate

193 interactions

Showing 60 of 193 moderate interactions — see all 193 on the N,n-dmpea page.

No interaction 2,636 drugs checked — show the list

We also checked N,n-dmpea against these medications and found no known interaction in our sources. Open any page to confirm.

Showing the 60 most looked-up of 2,636 medications checked with no known interaction — see the full N,n-dmpea list.

See the full N,n-dmpea interactions page
See every supplement checked against Inotuzumab Ozogamicin, ranked by severity
Evidence & sources

N,n-dmpea References

The 2 references that drive our N,n-dmpea monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Liu Y, Santillo MF. Cytochrome P450 2D6 and 3A4 enzyme inhibition by amine stimulants in dietary supplements. Drug Test Anal. 2016;8(3-4):307-10. PubMed
  2. Schoenwald RD, Vidvauns S, Wurster DE, Barfknecht CF. Tear film stability of protein extracts from dry eye patients administered a sigma agonist. J Ocul Pharmacol Ther 1997;13(2):151-61. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking N,n-dmpea and Inotuzumab Ozogamicin Together: Common Questions

Is it safe to take N,n-dmpea with Inotuzumab Ozogamicin?
We do not list a known interaction between N,n-dmpea and Inotuzumab Ozogamicin. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
How was the N,n-dmpea and Inotuzumab Ozogamicin combination checked?
Interactions in our licensed database are recorded against drug classes. Inotuzumab Ozogamicin is filed under 1 classification, and N,n-dmpea has documented interactions with 1 drug class — none of Inotuzumab Ozogamicin's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does N,n-dmpea interact with any other medications?
Yes. N,n-dmpea has 193 documented drug interactions in our database — Inotuzumab Ozogamicin is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Inotuzumab Ozogamicin interact with any supplements?
Yes. Inotuzumab Ozogamicin has documented interactions with 13 supplements in our database — N,n-dmpea is not one of them. The Inotuzumab Ozogamicin interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Where next

Keep Exploring

N,n-dmpea monograph Uses, safety profile, and every drug interaction in one place Inotuzumab Ozogamicin Injection drug information The full plain-English guide to this medication Inotuzumab Ozogamicin supplement interactions Every supplement checked against Inotuzumab Ozogamicin, ranked by severity Supplement interaction checker Check any supplement or product against your medications Browse medications A–Z Every drug we’ve checked against herbs & supplements References The 2 citations behind this page Ask a pharmacist Free, personal answer from our licensed team

Still Have a Question About Inotuzumab Ozogamicin and N,n-dmpea?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.